IBM halting sales of Watson AI tool for drug discovery amid sluggish growth

IBM is halting development and sales of its Watson artificial intelligence software to help pharmaceutical companies discover new treatments.

Lab strips James Watson of final honorary roles after his continuing racist statements

In a recent documentary, Watson refused to take back statements widely regarded as racist.

IBM isn’t retreating from using Watson in health care, CEO Rometty says

CEO Ginni Rometty spoke little about health care during an hourlong talk at #CES19, but afterward insisted that “Watson Health is a very important part” of IBM’s business.

‘I really don’t know what happened to Jim’: Friends ask where James Watson’s odious attitudes about race came from

Watson saw his double-helix discovery as proof of his view that intuition and opposing the establishment consensus are stronger guides to truth than empirical research.

Flu picks up & new James Watson documentary

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

LISTEN: Watson’s latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?

IBM Watson’s bet on China, a lucrative market for health business, starts to look shaky

EXCLUSIVE: Though IBM Watson is being used to treat #cancer patients in #China, the company is scrambling to respond to the same doubts that emerged about the technology in the U.S. and Europe.

How an IBM Watson Health rescue mission collapsed — and a top executive was ousted

IBM couldn't get its Watson software to reliably understand and analyze language in patient medical records, a critical task for delivering on its contracts with hospitals and drug companies.

Head of IBM Watson Health leaving post after company stumbles, growing criticism

Head of IBM Watson Health leaving post after company stumbles, growing criticism

Watson’s faulty treatment advice & 21st Century Cures update

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

IBM’s Watson supercomputer recommended ‘unsafe and incorrect’ cancer treatments, internal documents show

Slide decks presented last summer by an IBM Watson Health executive largely blame the problems on the training of Watson for Oncology by IBM engineers and doctors at the renowned Memorial Sloan Kettering Cancer Center.

Citing weak demand, IBM Watson Health to scale back hospital business

EXCLUSIVE: Top executives of IBM’s Watson Health division told employees at a meeting this week that they are scaling back part of their hospital business, citing softening demand in the market.

Archived chat: IBM Watson Health — the latest stumble and what it means for health care

STAT reporters Casey Ross and Ike Swetlitz broke news this week about what lies behind a recent round of layoffs at IBM Watson Health. Join them to hear more.

IBM Watson Health hampered by internal rivalries and disorganization, former employees say

When IBM launched its Watson Health division three years ago, promising to revolutionize medicine, not everyone in the sprawling technology company was on board.

IBM’s problems with Watson Health run deeper than recent layoffs, former employees say

IBM's expensive gamble on Watson Health hasn't been working out, former employees say.

Scientific luminaries threw James Watson a birthday party weeks before Eric Lander’s widely criticized toast

Cold Spring Harbor Laboratory held a full day meeting in April honoring James Watson — the icon of biology who has sullied his legacy with racist, anti-Semitic, and sexist statements — without triggering so much as a Twitter peep.

As Twitter explodes, Eric Lander apologizes for toasting James Watson

"People who have called this out are correct. I was wrong to toast, and I’m sorry," Eric Lander said.

STAT Plus Intelligence Briefing: IBM Watson Health — the latest stumble and what it means for health care

Thursday, June 14 12:00 p.m. ET STAT reporters Casey Ross and Ike Swetlitz broke news this week about what lies behind a recent round of layoffs at IBM Watson Health. Interviews with former employees revealed that IBM, after spending billions to acquire a trio of companies with vast stores of health data, had struggled to…

IBM to Congress: Watson will transform health care, so keep your hands off our supercomputer

A STAT examination shows the lengths to which IBM has gone to shield its prized Watson supercomputer from government scrutiny.

Watch: A new advertising tack for hospitals: IBM’s Watson supercomputer is in the house

IBM's Watson supercomputer is attractive to some hospitals because its cachet is a lure for cancer patients, who boost their bottom line.

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close

Three years after IBM began selling Watson for Oncology to recommend cancer treatments to doctors, it's falling short of the lofty expectations IBM created for it.

IBM Watson teams up with FDA to study blockchain for data

Add the FDA to the roster of healthcare clients lining up to work with IBM Watson. They’ll study how blockchain technology could be applied to healthcare.

Watson goes to Asia: Hospitals use supercomputer for cancer treatment

Clinicians use Watson to mine cancer patients' records and provide treatment advice in Thailand, India, and soon, China.

DNA pioneer James Watson: The cancer moonshot is ‘crap’ but there is still hope

James Watson discusses why the "cancer moonshot" is "all crap,"; why he remains hopeful that many cancers will be cured, nonetheless; and his own recovery from the disease.

Dr. Watson will see you now & changing payment for pain treatment

The STAT Morning Rounds newsletter keeps you ahead of the day's health and science news.

Study highlights challenges in using artificial intelligence to personalize cancer treatment

A new study details the challenges of using natural language processing, a subtype of AI, to identify patients likely to respond to targeted cancer therapies.

Aim your baloney detector at the BS in health care

Health care has an acute BS problem. Just think of Theranos and IBM Watson. Thanks to social media, it can spread faster and farther than the truth.

Pharmalittle: Sanofi pledge to rebuild Notre Dame gets backlash; IBM halts AI product for drug development

Sanofi pledged about $11 million for rebuilding Notre Dame, but reaction has been mixed.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy